Press Release VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets Aug 26
Press Release Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis Aug 26
Press Release Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients Aug 12